The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...
This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system.
In the wake of earning FDA clearance for its insulin pump and automated dosing software—which connect to a Dexcom continuous glucose monitor to create what’s known as a hybrid closed-loop system for ...
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from ...
Xeris Biopharma Holdings and Beta Bionics are working on the world's first dual-hormone pump to allow diabetics to tackle low blood sugar as well as high blood sugar. Chicago-based Xeris has entered ...
Beta Bionics Inc. received U.S. FDA clearance for its Ilet Bionic Pancreas, an automated insulin-delivery (AID) system that calculates 100% of insulin doses without requiring carb counting or manual ...
IRVINE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it expects to ...
Patch pump under development with commercialization expected by the end of 2027 One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results